FI900084A0 - Förfarande för framställning av terapeutiskt användbara bensimidazol-2-yl- och imidazo/4,5-b/pyridin-2-yl-amino- och -metyl-1-piperidinyletylderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara bensimidazol-2-yl- och imidazo/4,5-b/pyridin-2-yl-amino- och -metyl-1-piperidinyletylderivat

Info

Publication number
FI900084A0
FI900084A0 FI900084A FI900084A FI900084A0 FI 900084 A0 FI900084 A0 FI 900084A0 FI 900084 A FI900084 A FI 900084A FI 900084 A FI900084 A FI 900084A FI 900084 A0 FI900084 A0 FI 900084A0
Authority
FI
Finland
Prior art keywords
6alkyl
hydrogen
methyl
derivatives
piperidinylethyl
Prior art date
Application number
FI900084A
Other languages
English (en)
Finnish (fi)
Other versions
FI94526C (sv
FI94526B (sv
FI900084A (sv
Inventor
Frans Eduard Janssens
Ludo Edmond Josephine Kennis
Francois Maria Sommen
Ann Christina Joannes Dierckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI900084A0 publication Critical patent/FI900084A0/sv
Publication of FI900084A publication Critical patent/FI900084A/sv
Application granted granted Critical
Publication of FI94526B publication Critical patent/FI94526B/sv
Publication of FI94526C publication Critical patent/FI94526C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI900084A 1989-01-09 1990-01-08 Förfarande för framställning av terapeutiskt användbara bensimidazol-2-yl- och imidazo/4,5-b/pyridin-2-yl-amino- och -metyl-1-piperidinyletylderivat FI94526C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900380A GB8900380D0 (en) 1989-01-09 1989-01-09 2-aminopyrimidinone derivatives
GB8900380 1989-01-09

Publications (4)

Publication Number Publication Date
FI900084A0 true FI900084A0 (sv) 1990-01-08
FI900084A FI900084A (sv) 1990-07-10
FI94526B FI94526B (sv) 1995-06-15
FI94526C FI94526C (sv) 1995-09-25

Family

ID=10649777

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900084A FI94526C (sv) 1989-01-09 1990-01-08 Förfarande för framställning av terapeutiskt användbara bensimidazol-2-yl- och imidazo/4,5-b/pyridin-2-yl-amino- och -metyl-1-piperidinyletylderivat

Country Status (20)

Country Link
US (1) US5008268A (sv)
EP (1) EP0378254B1 (sv)
JP (1) JPH02233678A (sv)
CN (1) CN1030452C (sv)
AT (1) ATE107642T1 (sv)
AU (1) AU622509B2 (sv)
CA (1) CA2007198A1 (sv)
DE (1) DE69010015T2 (sv)
DK (1) DK0378254T3 (sv)
ES (1) ES2058749T3 (sv)
FI (1) FI94526C (sv)
GB (1) GB8900380D0 (sv)
HU (1) HU206350B (sv)
IE (1) IE63153B1 (sv)
IL (1) IL92729A0 (sv)
NO (1) NO172645C (sv)
NZ (1) NZ231787A (sv)
PH (1) PH26908A (sv)
RU (1) RU1825364C (sv)
ZA (1) ZA90120B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058527T3 (es) * 1988-06-16 1994-11-01 Smith Kline French Lab Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
NZ238863A (en) * 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
TW231291B (sv) * 1992-01-09 1994-10-01 Janssen Pharmaceutica Nv
GR1001393B (el) * 1992-10-12 1993-10-29 Janssen Pharmaceutica Nv Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
GR1001385B (el) * 1992-10-12 1993-10-29 Janssen Pharmaceutica Nv Παράγωγα ιμιδαζο 1,2-α (πυρρολο,?ειενο η φουρανο) 3,2-d αζεπίνης συν?έσεις και μέ?οδοι χρήσεως.
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
DK3150209T3 (da) 2006-03-31 2019-10-28 Vistakon Pharmaceuticals Llc Okulære allergibehandlinger
CN101671336B (zh) 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
CN112574219A (zh) * 2021-01-31 2021-03-30 湖北大学 一种苯并咪唑并嘧啶酮衍生物的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
US4835161A (en) * 1986-02-03 1989-05-30 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
EP0297742A3 (en) * 1987-06-22 1990-05-16 Elopak Systems Ag Flat top end closure for liquid containers
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
GB8716313D0 (en) * 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines

Also Published As

Publication number Publication date
HU206350B (en) 1992-10-28
IE900068L (en) 1990-07-09
EP0378254A3 (en) 1991-01-09
JPH02233678A (ja) 1990-09-17
FI94526C (sv) 1995-09-25
CA2007198A1 (en) 1990-07-09
DE69010015D1 (de) 1994-07-28
EP0378254B1 (en) 1994-06-22
NO900070D0 (no) 1990-01-08
NZ231787A (en) 1991-07-26
CN1044099A (zh) 1990-07-25
IE63153B1 (en) 1995-03-22
EP0378254A2 (en) 1990-07-18
ATE107642T1 (de) 1994-07-15
FI94526B (sv) 1995-06-15
NO172645B (no) 1993-05-10
ES2058749T3 (es) 1994-11-01
ZA90120B (en) 1991-09-25
AU4778090A (en) 1990-07-12
NO172645C (no) 1993-08-18
PH26908A (en) 1992-12-03
CN1030452C (zh) 1995-12-06
FI900084A (sv) 1990-07-10
DK0378254T3 (da) 1994-07-25
DE69010015T2 (de) 1994-11-24
HU900063D0 (en) 1990-03-28
AU622509B2 (en) 1992-04-09
HUT53364A (en) 1990-10-28
IL92729A0 (en) 1990-09-17
GB8900380D0 (en) 1989-03-08
NO900070L (no) 1990-07-10
RU1825364C (ru) 1993-06-30
US5008268A (en) 1991-04-16

Similar Documents

Publication Publication Date Title
FI900084A0 (sv) Förfarande för framställning av terapeutiskt användbara bensimidazol-2-yl- och imidazo/4,5-b/pyridin-2-yl-amino- och -metyl-1-piperidinyletylderivat
NO167979C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner
ZA884696B (en) ((bicyclic heterocyclyl)methyl and-hetero)substituted hexahydro-1h-azepines and pyrrolidines
FI882909A0 (sv) Förfarande för framställning av terapeutiskt användbara furanylmetylsubstituerade bensimidazol- och imidazopyridinderivat
FI901755A0 (sv) Förfarande för framställning av terapeutiskt aktiva hydroxialkylfuranylderivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.